2021-01-10,Chi-Med and Inmagene Announce Strategic Partnership to Develop and Commercialize Portfolio of Drug Candidates for Immunological Diseases
2020-12-30,Chi-Med Announces the NMPA Approval of Surufatinib (Sulanda® in China) for Non-Pancreatic Neuroendocrine Tumors
2020-12-28,Chi-Med Initiates Rolling Submission of NDA to U.S. FDA for Surufatinib for the Treatment of Advanced Neuroendocrine Tumors
2020-12-22,"This Basket of Chinese Stocks Could Rally Over 30%, Say Analysts"
2020-12-22,Chi-Med to Present at the 39th Annual JP Morgan Healthcare Conference
2020-11-30,Should I Avoid Hutchison China MediTech Limited (HCM)?
2020-11-17,Chi-Med Announces US$100 Million Equity Investment by CPP Investments
2020-11-05,Chi-Med Highlights HMPL-689 Clinical Data to be Presented at the 62nd ASH Annual Meeting
2020-10-30,Chi-Med to Attend Upcoming Industry and Investor Virtual Conferences
2020-10-20,How Much Is Hutchison China MediTech Limited (LON:HCM) CEO Getting Paid?
2020-09-20,Chi-Med Highlights Surufatinib Phase III Results in Neuroendocrine Tumors at ESMO 2020 and Publications in The Lancet Oncology
2020-09-17,Chi-Med Announces Second NDA Acceptance in China for Surufatinib in Pancreatic Neuroendocrine Tumors
2020-09-04,"Chi-Med Initiates FRESCO-2, a Global Phase III Trial of Fruquintinib in Metastatic Colorectal Cancer"
2020-09-03,Chi-Med Initiates a Phase II Trial of HMPL-453 in Patients with Advanced Intrahepatic Cholangiocarcinoma in China
2020-08-24,Chi-Med Highlights Clinical Data to be Presented at the Upcoming ESMO Virtual Congress 2020
2020-08-10,Edison issues ADR update on Hutchison China MediTech (HCM)
2020-08-10,Chi-Med Plans to Submit Marketing Authorization Application for Surufatinib Following Scientific Advice from EMAs CHMP
2020-07-30,Hutchison China MediTech Limited (HCM) Q2 2020 Earnings Call Transcript
2020-07-30,Chi-Med Reports 2020 Interim Results and Provides Updates on Key Clinical Programs
2020-07-28,Chi-Meds NDA for Savolitinib in Non-Small Cell Lung Cancer Granted Priority Review in China
2020-07-28,Chi-Med and Lilly to Collaborate in Commercializing Elunate® in China
2020-07-24,Chi-Med Initiates a Phase I Trial of IDH1/2 Dual Inhibitor in Patients with Hematological Malignancies in China
2020-07-22,Did Business Growth Power Hutchison China MediTech's (LON:HCM) Share Price Gain of 162%?
2020-07-06,Edison Issues ADR Outlook on Hutchison China MediTech (HCM)
2020-06-26,Chi-Med to Announce 2020 Half-Year Financial Results
2020-06-25,"The Daily Biotech Pulse: Merck's Wonder Cancer Drug Snags Another Approval, Decision Day For Zogenix, UniQure Out-Licenses Gene Therapy"
2020-06-25,Chi-Med Announces US$100 Million Equity Investment by General Atlantic
2020-06-18,Chi-Med Announces Fruquintinib Granted U.S. FDA Fast Track Designation for Metastatic Colorectal Cancer
2020-06-12,Is Hutchison China MediTech Limited (HCM) A Good Stock To Buy?
2020-06-09,Chi-Med Announces US$95 million Guangzhou Land Compensation Agreement
2020-06-04,Chi-Med Announces the Continuation of Phase III FRUTIGA Study of Fruquintinib in Second-Line Gastric Cancer in China Following a Planned Interim Data Review
2020-06-01,Chi-Med Plans to Submit NDA for Surufatinib Following Pre-NDA Meeting with the U.S. FDA
2020-05-29,Chi-Med to Discuss Select Global Clinical Trial Data Presented at ASCO20
2020-05-29,Chi-Med Announces NDA Acceptance in China for Savolitinib in the Treatment of Non-Small Cell Lung Cancer with MET Exon 14 Skipping Mutations
2020-05-26,"Chi-Med, BeiGene Join Forces For Solid Cancer Tumor Treatment"
2020-05-26,Chi-Med and BeiGene Enter into Clinical Collaboration to Evaluate Combinations of Surufatinib and Fruquintinib with Tislelizumab
2020-05-14,Chi-Med Highlights Clinical Data to be Presented at the Upcoming ASCO20 Virtual Scientific Program
2020-05-11,SE Asia Stocks-Rise as China signals more policy measures to support economy
2020-05-08,Chi-Med to Attend Upcoming Investor Conferences
2020-04-23,Should You Worry About Hutchison China MediTech Limited's (LON:HCM) CEO Pay?
2020-04-22,Edison Issues ADR Update on Hutchison China MediTech (HCM)
2020-04-22,Chi-Med Highlights Presentations of Surufatinib at the Upcoming AACR Virtual Annual Meetings
2020-04-17,"The Daily Biotech Pulse: Moderna Secures $483M In BARDA Funding, Gilead Remdesivir Data, Veracyte's Positive Pre-Announcement"
2020-04-17,Chi-Med Announces Surufatinib Granted U.S. FDA Fast Track Designations for the Treatment of Both Pancreatic and Non-Pancreatic Neuroendocrine Tumors
2020-04-07,Do Hedge Funds Love Hutchison China MediTech Limited (HCM)?
2020-03-31,Chi-Med Initiates a Phase II Trial of HMPL-453 in Patients with Advanced Malignant Mesothelioma in China
2020-03-26,Deutsche Bank's Depositary Receipts Virtual Investor Conference presentations now available for on-demand viewing
2020-03-26,Deutsche Bank's Depositary Receipts Virtual Investor Conference presentations now available for On-Demand Viewing
2020-03-16,"International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on March 18th and 19th, 2020"
2020-03-10,"International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on March 18th and 19th, 2020"
2020-03-05,Hutchison China MediTech (HCM) Upgraded to Buy: What Does It Mean for the Stock?
2020-03-03,Chi-Med Reports 2019 Full Year Results and Provides Updates on Key Clinical Programs
2020-02-25,"Chi-Med to announce 2019 Final Results on Tuesday, March 3, 2020  adjustment to announcement and presentation logistics due to travel restrictions"
2020-02-12,RPT-FOCUS-Coronavirus outbreak begins to disrupt booming China drug trials
2020-02-12,FOCUS-Coronavirus outbreak begins to disrupt booming China drug trials
2020-02-10,Chi-Med Highlights Updated Phase II Savolitinib / Imfinzi® Combination Data in Advanced Papillary Renal Cell Carcinoma at 2020 ASCO Genitourinary Cancers Symposium
2020-02-06,Chi-Med Announces the Exercise of Underwriters Over-allotment Option for Public Offering of ADSs
2020-01-31,Chi-Med to Announce 2019 Final Results
2020-01-23,Hutchison China MediTech Limited Just Released Its Third-Quarter Earnings: Here's What Analysts Think
2020-01-23,Chi-Med Announces Pricing of US$110 Million Public Offering of ADSs
2020-01-21,Chi-Med Announces Proposed Public Offering of ADSs
2020-01-21,Moving Average Crossover Alert: Hutchison China MediTech
2020-01-20,Will Hutchison China MediTech Continue to Surge Higher?
2020-01-20,Chi-Med Announces that Surufatinib Phase III SANET-p Study Has Already Achieved its Primary Endpoint in Advanced Pancreatic Neuroendocrine Tumors in China and Will Stop Early
2020-01-16,Hutchison China MediTech (HCM) Is Up 0.6% in One Week: What You Should Know
2020-01-13,Chi-Med Initiates a Phase II Trial of Surufatinib in Combination with Tuoyi in Patients with Advanced Solid Tumors
2020-01-06,Chi-Med to Present at the 38th Annual JP Morgan Healthcare Conference
2019-12-20,Chi-Meds New Drug Application for Surufatinib in Non-Pancreatic Neuroendocrine Tumors Granted Priority Review in China
2019-12-14,Hedge Funds Arent Crazy About Hutchison China MediTech Limited (HCM) Anymore
2019-12-09,Highlights From The Deutsche Bank ADR Virtual Investor Conference
2019-11-29,Edison issues ADR update on Hutchison China MediTech (HCM)
2019-11-28,Chi-Meds Elunate® (Fruquintinib Capsules) Included in the National Reimbursement Drug List in China
2019-11-25,Chi-Med Announces Surufatinib Granted FDA Orphan Drug Designation for Pancreatic Neuroendocrine Tumors
2019-11-22,Chi-Med Highlights Oral Presentations at 2019 ESMO Asia Annual Meeting
2019-11-15,Deutsche Bank's Depositary Receipts Virtual Investor Conference presentations now available for On-Demand Viewing
2019-11-15,How Much Of Hutchison China MediTech Limited (LON:HCM) Do Institutions Own?
2019-11-11,Chi-Med Announces NDA Acceptance in China for Surufatinib in Non-Pancreatic Neuroendocrine Tumors
2019-11-06,"International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on November 13th and 14th, 2019"
2019-11-06,"International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on November 13th and 14th, 2019"
2019-10-29,Hedge Funds Have Never Been This Bullish On Hutchison China MediTech Limited (HCM)
2019-10-17,Chi-Med highlights publication of Phase II data showing promising efficacy for Savolitinib in MET-amplified gastric cancers
2019-10-10,Edison issues ADR update on Hutchison China MediTech (HCM)
2019-10-10,Innovent and Chi-Med Expand Global Collaboration to Evaluate the Combination of Sintilimab and Surufatinib in Solid Tumors
2019-10-04,Chi-Med Initiates an International Phase I/Ib Trial of HMPL-523 in Patients with Advanced Relapsed or Refractory Lymphoma
2019-10-01,Investors Who Bought Hutchison China MediTech (LON:HCM) Shares Five Years Ago Are Now Up 152%
2019-09-30,CK Hutchison prices offering of Chi-Med share capital enabling deconsolidation and confirms its intention to hold Chi-Med as a strategic investment for the long term
2019-09-30,Hutchison China MediTech Solutions Enters Oversold Territory
2019-09-30,CK Hutchison offers 1.3% of Chi-Meds share capital aiming to deconsolidate and hold Chi-Med as a strategic investment for the long term
2019-09-29,Chi-Med to Discuss Surufatinib Phase III and U.S. Phase I/Ib Efficacy and Safety Data Presented at the 2019 ESMO Annual Meeting
2019-09-25,Chi-Med Highlights Presentation of Clinical Data from the Successful SANET-ep Phase III Trial at ESMO Annual Meeting
2019-09-18,Chi-Med Highlights Oral Presentations at 2019 CSCO Annual Meeting
2019-09-16,Top Ranked Momentum Stocks to Buy for September 16th
2019-09-03,Chi-Med to Participate in the Morgan Stanley 17th Annual Global Healthcare Conference
2019-09-03,Chi-Med Initiates an International Phase I/Ib Trial of HMPL-689 in Patients with Advanced Relapsed or Refractory Lymphoma
2019-08-26,Does Hutchison China MediTech Limited's (LON:HCM) CEO Pay Compare Well With Peers?
2019-08-23,Chi-Med Initiates a Phase I Trial of HMPL-523 in Patients with Immune Thrombocytopenia (ITP) in China
2019-08-14,Edison issues ADR update on Hutchison China MediTech (HCM)
2019-07-30,Hutchison China MediTech Limited (HCM) Q2 2019 Earnings Call Transcript
2019-07-30,Chi-Med Reports 2019 Interim Results and Provides Updates on Key Clinical Programs
2019-07-19,Credit Suisse initiates coverage of AMC with optimistic outlook
